PubMed:11773892 / 346-467
Annnotations
LitCoin-entities
{"project":"LitCoin-entities","denotations":[{"id":"411","span":{"begin":46,"end":54},"obj":"OrganismTaxon"},{"id":"412","span":{"begin":90,"end":113},"obj":"DiseaseOrPhenotypicFeature"},{"id":"413","span":{"begin":115,"end":119},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A8","pred":"db_id","subj":"411","obj":"NCBITaxon:9606"},{"id":"A9","pred":"db_id","subj":"412","obj":"MESH:D007676"},{"id":"A10","pred":"db_id","subj":"413","obj":"MESH:D007676"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Recently, however, we have had an increase of patients who are presenting after OLTX with end-stage renal disease (ESRD)."}
LitCoin-sentences
{"project":"LitCoin-sentences","denotations":[{"id":"T5","span":{"begin":0,"end":121},"obj":"Sentence"}],"text":"Recently, however, we have had an increase of patients who are presenting after OLTX with end-stage renal disease (ESRD)."}
LitCoin-GeneOrGeneProduct-v0
{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T8","span":{"begin":90,"end":93},"obj":"GeneOrGeneProduct"}],"text":"Recently, however, we have had an increase of patients who are presenting after OLTX with end-stage renal disease (ESRD)."}
LitCoin-Disease-MeSH
{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T4","span":{"begin":90,"end":113},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":115,"end":119},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"originalLabel","subj":"T4","obj":"D007676"},{"id":"A5","pred":"originalLabel","subj":"T5","obj":"D007676"}],"text":"Recently, however, we have had an increase of patients who are presenting after OLTX with end-stage renal disease (ESRD)."}
LitCoin_Mondo_095
{"project":"LitCoin_Mondo_095","denotations":[{"id":"T2","span":{"begin":115,"end":119},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0004375"}],"text":"Recently, however, we have had an increase of patients who are presenting after OLTX with end-stage renal disease (ESRD)."}
LitCoin-MeSH-Disease-2
{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T4","span":{"begin":90,"end":113},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":115,"end":119},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"ID:","subj":"T4","obj":"D007676"},{"id":"A5","pred":"ID:","subj":"T5","obj":"D007676"}],"text":"Recently, however, we have had an increase of patients who are presenting after OLTX with end-stage renal disease (ESRD)."}
LitCoin-MONDO_bioort2019
{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T4","span":{"begin":90,"end":113},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":115,"end":119},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"#label","subj":"T4","obj":"D007676"},{"id":"A5","pred":"#label","subj":"T5","obj":"D007676"}],"text":"Recently, however, we have had an increase of patients who are presenting after OLTX with end-stage renal disease (ESRD)."}
LitCoin-NCBITaxon-2
{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T1","span":{"begin":46,"end":54},"obj":"OrganismTaxon"}],"text":"Recently, however, we have had an increase of patients who are presenting after OLTX with end-stage renal disease (ESRD)."}
LitCoin-training-merged
{"project":"LitCoin-training-merged","denotations":[{"id":"T92273","span":{"begin":115,"end":119},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T4","span":{"begin":90,"end":113},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T57722","span":{"begin":46,"end":54},"obj":"OrganismTaxon"}],"attributes":[{"id":"A72254","pred":"#label","subj":"T92273","obj":"D007676"},{"id":"A55821","pred":"#label","subj":"T4","obj":"D007676"}],"text":"Recently, however, we have had an increase of patients who are presenting after OLTX with end-stage renal disease (ESRD)."}